InvestorsHub Logo

bennyboy1

11/03/18 10:28 AM

#170887 RE: XenaLives #170884

Xena - If nothing else, Australia has a new policy that can allow conditional approval at an early point in a trial if it wants to, and based on the Alzheimer 2-73 Trial, Anavex with success is now in position to have an early conditional approval in Australia. Just imagine how extremely important that would be, and BLOCKBUSTER news to say the least. Can't help but feel excited for us and millions. We are not there yet, but it is on the drawing board - COMING SOON!!!!!!!!!!